Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy

Oncology Letters

Volumn 3, Issue 3, 2012, Pages 571-576

  Abe, Akiko ^a   Furumoto, Hiroyuki ^a   Nishimura, Masato ^a   Irahara, Minoru ^a   Ikushima, Hitoshi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Adjuvant chemotherapy; Cervical cancer; Chemoradiation; Lymphadenopathy

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; LYMPHADENOPATHY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

EID: 84855705852     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.516     Document Type: Article

References (22)

1. Center for Cancer Control and Information Services, National Cancer Center, Japan, 2010 (ganjoho.jp).
2. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para- aortic radiation for high-risk cervical cancer. N Engl J Med 340: 1137-1143, 1999.
3. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL and Insalaco S: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144-1153, 1999.
4. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL and Liao SY: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17: 1339-1348, 1999.
5. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL III, Walker JL and Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154-1161, 1999.
6. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch DG: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22: 872-880, 2004.
7. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Colingwood M and Williams CJ: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358: 781-786, 2001.
8. Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO and Kim GE: Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Gynecol Oncol 104: 58-63, 2007.
9. Choi CH, Lee JW, Kim WY, Nam HR, Kim BG, Hum SJ, Lee JH and Bae DS: Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results. Int J Rad Oncol Biol Phys 68: 817-822, 2007.
10. Japan Society of Gynecologic Oncology: Cervical cancer treatment guidelines, 2007.
11. Ikushima H, Osaki K, Furutani S, Yamashita K, Kawanaka T, Kishida Y, Wamoto S, Takegawa Y, Kudoh T and Nishitani H: Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin. Rad Med 24: 115-121, 2006.
12. Sakuragi N: Up-to-date management of lymph node metastasis and the role of tailred lymphadenenctomy in cervical cancer. Int J Clin Oncol 12: 165-175, 2007.
13. Berman ML, Keys H, Creasman W, Reasman W, DiSaia P, Bundy B and Blessing J: Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes. Gynecol Oncol 19: 8-16, 1984.
14. Benedetti PP, Basile S and Angioli R: Pelvic and aortic lymph- adenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact. Gynecol Oncol 113: 284-290, 2009.
15. Vidaurreta J, Bermudez A, Di Paola G and Sardi J: Laparoscopic staging in locally advanced cervical carcinoma: a new possible philosophy? Gynecol Oncol 75: 366-371, 1999.
16. Grigsby PW, Dehdashi F and Siegel BA: FDG-PET evaluation of carcinoma of the cervix. Clin Pos Image 2: 105-109, 1999.
17. Rose PG and Bundy BN: Chemoradiation for locally advanced cervical cancer: does it help? J Clin Oncol 20: 891-893, 2002.
18. Grigsby PW, Perez CA, Chao KS, Herog T, Mutch DG and Rader J: Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Rad Oncol Biol Phys 49: 733-738, 2001.
19. Walker JL, Morrison A, DiSilvestro P and von Gruenige VE: A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes. Gynecol Oncol 112: 78-84, 2009.
20. Zhang MQ, Liu SP and Wang XE: Concurrent chemotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of phase II study. Int Rad Oncol Biol Phys 78: 821-827, 2010.
21. Rose PG, Lessing JA, Gershenson DM and McGehee R: Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 17: 2676-2680, 1999.
22. Sit AS, Kelley JL, Gallion HH, Kunschner AJ and Edwards RP: Paclitaxel and carboplatin for recurrence or persistent cancer of the cervix. Cancer Invest 22: 368-373, 2004.